Dr. Given has served as an external director of the Company since September 2004. He became Chairman in January 2010.
From March 2002 until June 2007 he served as President and Chief Executive Officer of Encysive Pharmaceuticals Inc. Previously, Dr. Given has held various positions in Johnson & Johnson group companies. Dr. Given obtained his doctorate from the University of Chicago in 1980.
Peter Gray is the Chief Executive of ICON. He has been with the company since 1997, initially as CFO and later as COO. He became CEO in 2002.
Peter has over 19 years experience in the pharmaceutical services industry and has also worked in the engineering and food sectors. Peter qualified in Law from Trinity College Dublin in 1977 and with KPMG became a chartered accountant in 1980.
Dr. John Climax, one of ICON's co-founders, was Chairman from November 2002 to December 2009. Prior to that, from June 1990 to November 2002 he served as Chief Executive of the Company . He has over 25 years of experience in the contract research industry globally.
John received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his PhD in clinical pharmacology from the National University of Ireland in 1982.
He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland.
Dr. Lambe, one of the Company’s co-founders, served as Chairman of the Board of the Company from June 1990 to November 2002.
He has been a non executive director since January 2008. Dr. Lambe has over 30 years experience in the contract research industry. Dr. Lambe attended the National University of Ireland where he received his Bachelor of Science degree in chemistry in 1959, his masters in biochemistry in 1962 and his PhD. in pharmacology in 1976.
Mr. Lynch has served as an external director of the company since January 1996.
Mr. Lynch served as a director of Nanogen Inc., from 1996 to 2000. Mr. Lynch is currently a non-executive director of Amarin Corporation plc, a director of Royal Opera House (Covent Garden) and a non-executive director of IDA Ireland.
In the period from May 1993 to July 2004, Mr. Lynch held several senior positions in Elan Corporation, plc, a specialty pharmaceutical company, including Executive Vice President, Chief Financial Officer, Vice Chairman and Senior Advisor to the Chairman of the Board of Elan Corporation, plc. Mr. Lynch was a partner at KPMG from May 1990 to May 1993.
Professor Dermot Kelleher joined the ICON board as an external director in May 2008.
Professor Kelleher is currently Head of the School of Medicine at Trinity College, Dublin, Ireland and Director of the Institute of Molecular Medicine in Dublin. His research interests are broad ranging in the fields of Gastroenterology, Immunology and Molecular Biology and over a distinguished thirty year career he has led significant research projects in this field.
Alongside his notable academic appointments he has served as a visiting research scientist with a major pharmaceutical company and has been a founder of a number of biotechnology companies
Declan McKeon was appointed as a non-executive director in April 2010
Mr. McKeon was a partner in PricewaterhouseCoopers (PwC) from 1986-2007. Declan's roles included leadership of the audit and business advisory team for PwC Ireland, membership on the PwC Europe audit and business advisory services executive and market sector lead for consumer and industrial products. Declan is a non-executive Director of Ryanair plc, he remains a consultant to PwC and sits on the audit committee of the Royal College of Surgeons in Ireland.
Declan holds a Bachelor of Commerce and Masters in Business Studies from University College Dublin and is a Fellow of The Institute of Chartered Accountants in Ireland.
Anthony J. Murphy, Ph.D joined the ICON board as an external director in April 2009.
Dr. Murphy was the senior vice president of human resources for Eli Lilly & Co., prior to his retirement in May 2009.
Born in Cardiff, Wales, Mr. Murphy received a bachelor's degree in psychology from University College Dublin in 1970 and a doctorate in psychology from the University of Wales in 1975. Mr. Murphy joined Lilly (in the United Kingdom) in 1980, and held increasingly senior positions in HR, with the company until his retirement. Prior to that he had lectured in industrial relations and worked as a consultant and researcher at the University of Bath, England. Mr. Murphy is a fellow of the Institute of Personnel and Development (U.K.) and a Chartered Psychologist.
Ciaran Murray has served as Chief Financial Officer of ICON plc since October 2005.
Ciaran developed his experience in senior financial positions in the food sector with Kraft Foods Inc, Cantrell and Cochrane plc and Northern Foods plc, and in the technology sector with Novell Inc and Codec Systems, a privately held Irish technology group where he served as Chief Financial Officer from 1999 to 2005, immediately prior to joining ICON plc.
Mr. Murray obtained a Bachelor of Commerce degree from University College Dublin in 1982. He qualified as a Chartered Accountant with PwC and is a Fellow of the Institute of Chartered Accountants in Ireland.